Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
RecombinantRabMAb

Recombinant Anti-TIE2 antibody [EPR21915] (ab221154)

Submit a review Submit a question References (5)
Indirect ELISA - Anti-TIE2 antibody [EPR21915] (ab221154)
  • Western blot - Anti-TIE2 antibody [EPR21915] (ab221154)
  • Flow Cytometry - Anti-TIE2 antibody [EPR21915] (ab221154)
  • Immunocytochemistry/ Immunofluorescence - Anti-TIE2 antibody [EPR21915] (ab221154)
  • Anti-TIE2 antibody [EPR21915] (ab221154)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR21915] to TIE2
  • Suitable for: Indirect ELISA, WB, ICC/IF, Flow Cyt
  • Reacts with: Mouse, Human

Conjugates logo Related conjugates and formulations

Alexa Fluor® 488 Alexa Fluor® 647 APC Carrier Free PE

Overview

  • Product name

    Anti-TIE2 antibody [EPR21915]
    See all TIE2 primary antibodies

  • Description

    Rabbit monoclonal [EPR21915] to TIE2

  • Host species

    Rabbit

  • Tested applications

    Suitable for: Indirect ELISA, WB, ICC/IF, Flow Cytmore details

  • Species reactivity

    Reacts with: Mouse, Human

  • Immunogen

    Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB: Human lung lysate; HUVEC and U-87 MG whole cell lysates. ICC/IF: HUVEC cells. Flow cyt: HUVEC cells. Indirect ELISA: Human and Mouse TEK.

  • General notes

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

Applications

The Abpromise guarantee

Our Abpromise guarantee covers the use of ab221154 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Indirect ELISA
Use a concentration of 0.25 µg/ml.
WB
1/1000. Detects a band of approximately 160, 50, 40 kDa (predicted molecular weight: 126 kDa).
ICC/IF
1/4000.
Flow Cyt
1/500.
Notes
Indirect ELISA
Use a concentration of 0.25 µg/ml.
WB
1/1000. Detects a band of approximately 160, 50, 40 kDa (predicted molecular weight: 126 kDa).
ICC/IF
1/4000.
Flow Cyt
1/500.

Target

  • Function

    Tyrosine-protein kinase that acts as cell-surface receptor for ANGPT1, ANGPT2 and ANGPT4 and regulates angiogenesis, endothelial cell survival, proliferation, migration, adhesion and cell spreading, reorganization of the actin cytoskeleton, but also maintenance of vascular quiescence. Has anti-inflammatory effects by preventing the leakage of proinflammatory plasma proteins and leukocytes from blood vessels. Required for normal angiogenesis and heart development during embryogenesis. Required for post-natal hematopoiesis. After birth, activates or inhibits angiogenesis, depending on the context. Inhibits angiogenesis and promotes vascular stability in quiescent vessels, where endothelial cells have tight contacts. In quiescent vessels, ANGPT1 oligomers recruit TEK to cell-cell contacts, forming complexes with TEK molecules from adjoining cells, and this leads to preferential activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascades. In migrating endothelial cells that lack cell-cell adhesions, ANGT1 recruits TEK to contacts with the extracellular matrix, leading to the formation of focal adhesion complexes, activation of PTK2/FAK and of the downstream kinases MAPK1/ERK2 and MAPK3/ERK1, and ultimately to the stimulation of sprouting angiogenesis. ANGPT1 signaling triggers receptor dimerization and autophosphorylation at specific tyrosine residues that then serve as binding sites for scaffold proteins and effectors. Signaling is modulated by ANGPT2 that has lower affinity for TEK, can promote TEK autophosphorylation in the absence of ANGPT1, but inhibits ANGPT1-mediated signaling by competing for the same binding site. Signaling is also modulated by formation of heterodimers with TIE1, and by proteolytic processing that gives rise to a soluble TEK extracellular domain. The soluble extracellular domain modulates signaling by functioning as decoy receptor for angiopoietins. TEK phosphorylates DOK2, GRB7, GRB14, PIK3R1; SHC1 and TIE1.

  • Tissue specificity

    Detected in umbilical vein endothelial cells. Proteolytic processing gives rise to a soluble extracellular domain that is detected in blood plasma (at protein level). Predominantly expressed in endothelial cells and their progenitors, the angioblasts. Has been directly found in placenta and lung, with a lower level in umbilical vein endothelial cells, brain and kidney.

  • Involvement in disease

    Dominantly inherited venous malformations
    May play a role in a range of diseases with a vascular component, including neovascularization of tumors, psoriasis and inflammation.

  • Sequence similarities

    Belongs to the protein kinase superfamily. Tyr protein kinase family. Tie subfamily.
    Contains 3 EGF-like domains.
    Contains 3 fibronectin type-III domains.
    Contains 2 Ig-like C2-type (immunoglobulin-like) domains.
    Contains 1 protein kinase domain.

  • Domain

    The soluble extracellular domain is functionally active in angiopoietin binding and can modulate the activity of the membrane-bound form by competing for angiopoietins.

  • Post-translational
    modifications

    Proteolytic processing leads to the shedding of the extracellular domain (soluble TIE-2 alias sTIE-2).
    Autophosphorylated on tyrosine residues in response to ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Autophosphorylation occurs in a sequential manner, where Tyr-992 in the kinase activation loop is phosphorylated first, followed by autophosphorylation at Tyr-1108 and at additional tyrosine residues. ANGPT1-induced phosphorylation is impaired during hypoxia, due to increased expression of ANGPT2. Phosphorylation is important for interaction with GRB14, PIK3R1 and PTPN11. Phosphorylation at Tyr-1102 is important for interaction with SHC1, GRB2 and GRB7. Phosphorylation at Tyr-1108 is important for interaction with DOK2 and for coupling to downstream signal transduction pathways in endothelial cells. Dephosphorylated by PTPRB.
    Ubiquitinated. The phosphorylated receptor is ubiquitinated and internalized, leading to its degradation.

  • Cellular localization

    Cell membrane. Cell junction. Cell junction, focal adhesion. Cytoplasm, cytoskeleton. Secreted. Recruited to cell-cell contacts in quiescent endothelial cells. Colocalizes with the actin cytoskeleton and at actin stress fibers during cell spreading. Recruited to the lower surface of migrating cells, especially the rear end of the cell. Proteolytic processing gives rise to a soluble extracellular domain that is secreted.
  • Information by UniProt

  • Database links

    • Alternative names

      • Angiopoietin 1 receptor antibody
      • Angiopoietin-1 receptor antibody
      • CD202b antibody
      • CD202b antigen antibody
      • Endothelial tyrosine kinase antibody
      • Endothelium specific receptor tyrosine kinase 2 antibody
      • hTIE 2 antibody
      • hTIE2 antibody
      • Hyk antibody
      • p140 TEK antibody
      • Soluble TIE2 variant 1 antibody
      • Soluble TIE2 variant 2 antibody
      • Tek antibody
      • tek tyrosine kinase antibody
      • TEK tyrosine kinase endothelial antibody
      • tek tyrosine kinase, endothelial antibody
      • TIE 2 antibody
      • TIE2 antibody
      • TIE2_HUMAN antibody
      • Tunica interna endothelial cell kinase antibody
      • Tyrosine kinase with Ig and EGF homology domains 2 antibody
      • Tyrosine kinase with Ig and EGF homology domains-2 antibody
      • Tyrosine protein kinase receptor TEK antibody
      • Tyrosine protein kinase receptor TIE 2 antibody
      • Tyrosine-protein kinase receptor TEK antibody
      • Tyrosine-protein kinase receptor TIE-2 antibody
      • Venous malformations multiple cutaneous and mucosal antibody
      • VMCM 1 antibody
      • VMCM antibody
      • VMCM1 antibody
      see all

    Images

    • Indirect ELISA - Anti-TIE2 antibody [EPR21915] (ab221154)
      Indirect ELISA - Anti-TIE2 antibody [EPR21915] (ab221154)

      Indirect ELISA showing primary antibody ab221154 binding to mouse TEK and Human TEK. Antigen concentration is 1000 ng/ml.

      Binding of ab221154 was assessed in a serial dilution range 1000-0 ng/ml.

      Binding was detected using the secondary antibody, Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution.

    • Western blot - Anti-TIE2 antibody [EPR21915] (ab221154)
      Western blot - Anti-TIE2 antibody [EPR21915] (ab221154)
      All lanes : Anti-TIE2 antibody [EPR21915] (ab221154) at 1/1000 dilution

      Lane 1 : Human lung tissue lysate
      Lane 2 : HUVEC (human umbilical vein endothelial cell line) whole cell lysate
      Lane 3 : U-87 MG (human glioblastoma-astrocytoma epithelial cell line) whole cell lysate
      Lane 4 : HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate

      Lysates/proteins at 20 µg per lane.

      Secondary
      Lane 1 : VeriBlot for IP Detection Reagent (HRP) (ab131366) at 1/1000 dilution
      Lanes 2-4 : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution

      Predicted band size: 126 kDa
      Observed band size: 160,40,50 kDa why is the actual band size different from the predicted?


      Exposure time: 3 minutes


      Blocking and dilution buffer: 5% NFDM/TBST.

      The molecular mass observed is consistent with what has been described in the literature (PMID: 26666854). The antibody detects multiple bands (≤ 50 kDa) which are likely to be cleavage fragments of Tie2.

      Negative control: HEK-293T (PMID: 15851516).

      This blot was developed using a high sensitivity ECL substrate.

       

    • Flow Cytometry - Anti-TIE2 antibody [EPR21915] (ab221154)
      Flow Cytometry - Anti-TIE2 antibody [EPR21915] (ab221154)

      Flow cytometric analysis of HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) (left panel) and HUVEC (human umbilical vein endothelial cell line) (right panel) cells labeling TIE2 with ab221154 at 1/500 dilution (red) compared with a Rabbit monoclonal IgG (ab172730) Isotype control (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077), at 1/2000 dilution was used as the secondary antibody.

      Gated on viable cells.

      Negative control: HEK-293T (PMID: 17189382)

    • Immunocytochemistry/ Immunofluorescence - Anti-TIE2 antibody [EPR21915] (ab221154)
      Immunocytochemistry/ Immunofluorescence - Anti-TIE2 antibody [EPR21915] (ab221154)

      Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HUVEC (human umbilical vein endothelial cell line) cells labeling TIE2 with ab221154 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing membranous and cytoplasmic staining in HUVEC cell line is observed. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).

      Control: Used PBS instead of primary antibody, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

      Negative control: HEK-293T (PMID: 17189382).

    • Anti-TIE2 antibody [EPR21915] (ab221154)
      Anti-TIE2 antibody [EPR21915] (ab221154)

    Protocols

    To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.

    Click here to view the general protocols

    References (5)

    Publishing research using ab221154? Please let us know so that we can cite the reference in this datasheet.

    ab221154 has been referenced in 5 publications.

    • Zhang Z  et al. Combined treatment of marizomib and cisplatin modulates cervical cancer growth and invasion and enhances antitumor potential in vitro and in vivo. Front Oncol 12:974573 (2022). PubMed: 36110967
    • Zhuang J  et al. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer. Int J Nanomedicine 16:1961-1976 (2021). PubMed: 33727809
    • Zhao Y  et al. Activated mesangial cells induce glomerular endothelial cells proliferation in rat anti-Thy-1 nephritis through VEGFA/VEGFR2 and Angpt2/Tie2 pathway. Cell Prolif 54:e13055 (2021). PubMed: 33987885
    • Li Z  et al. miR-25-5p regulates endothelial progenitor cell differentiation in response to shear stress through targeting ABCA1. Cell Biol Int 45:1876-1886 (2021). PubMed: 33945659
    • Koch PD  et al. Imaging of Tie2 with a Fluorescently Labeled Small Molecule Affinity Ligand. ACS Chem Biol 15:151-157 (2020). PubMed: 31809013

    Customer reviews and Q&As

    Show All Reviews Q&A
    Submit a review Submit a question

    There are currently no Customer reviews or Questions for ab221154.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com